Seasonal vaccine and H1N1: Authors' reply

BMJ (Online)

Volumn 339, Issue 7732, 2009, Pages 1214-

  Garcia Garcia, Lourdes ^a   Valdespino Gómez, Jose Luis ^b  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b Laboratorios de Biológicos Y Reactivos de México BIRMEX   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; NEUTRALIZING ANTIBODY;

CHRONIC RESPIRATORY TRACT DISEASE; DRUG EFFICACY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INTERVIEW; LETTER; MEXICO; PATIENT; PRIORITY JOURNAL; RELATIVE; VIRUS STRAIN;

EID: 71749114180     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b4978     Document Type: Letter

References (5)

1. Janjua NZ, Skowronski DM, Hottes TS, De Serres G, Crowcroft NS, Rosella LC. Selection bias explains seasonal vaccine's protection. BMJ 2009;339:b4972.[Free Full Text]
2. Demicheli V, Di Pietrantonj C, Jefferson T, Rivetti A, Rivetti D. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2007;(2):CD001269. (Pubitemid 351805943)
3. Mogabgab WJ, Leiderman E. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines. JAMA 1970;211:1672-1676[Abstract/Free Full Text]
4. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci USA 2004;101:3166-3171[Abstract/Free Full Text]
5. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009;58:521-524[Medline]